NEWTOWN, Pa., Oct. 02, 2023 Helius Medical Technologies, Inc. , a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today.
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q2 2023 Earnings Call Transcript August 10, 2023 Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.11. Operator: Good day, and thank you for standing by. Welcome to the Helius Medical Technologies, Inc. Q2 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s […]
NEWTOWN, Pa., June 14, 2023 Helius Medical Technologies, Inc. , a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today. | June 14, 2023